Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Structure/Function Claims In Ads Would Be Allowed Under House Bill

This article was originally published in The Tan Sheet

Executive Summary

A bill proposing structure/function claims deemed acceptable for dietary supplement labeling also be allowable for dietary supplement advertising was introduced Sept. 16 on the House floor by Rep. Michael Crapo (R-Idaho).

You may also be interested in...



Supplement advertising bill

Legislation that would allow the same claims permitted in dietary supplement product labeling to appear in consumer advertising introduced by Sen. Michael Crapo (R-Idaho) Oct. 19. The Dietary Supplement Fairness in Labeling and Advertising Act (S 1749) is similar to the bill Crapo introduced last session while a member of the House (1"The Tan Sheet" Oct. 5, 1998, p. 8). The new version, however, also would make FDA rescind its April 29 proposed rule on what constitutes an acceptable structure/function claim. In floor comments made when introducing the bill, Crapo stated that, with the proposal, FDA was "asserting responsibilities beyond congressional intent." The bill has been referred to the Senate Health, Education, Labor & Pensions Committee

Supplement advertising bill

Legislation that would allow the same claims permitted in dietary supplement product labeling to appear in consumer advertising introduced by Sen. Michael Crapo (R-Idaho) Oct. 19. The Dietary Supplement Fairness in Labeling and Advertising Act (S 1749) is similar to the bill Crapo introduced last session while a member of the House (1"The Tan Sheet" Oct. 5, 1998, p. 8). The new version, however, also would make FDA rescind its April 29 proposed rule on what constitutes an acceptable structure/function claim. In floor comments made when introducing the bill, Crapo stated that, with the proposal, FDA was "asserting responsibilities beyond congressional intent." The bill has been referred to the Senate Health, Education, Labor & Pensions Committee

Supplement advertising bill

Legislation that would allow the same claims permitted in dietary supplement product labeling to appear in consumer advertising introduced by Sen. Michael Crapo (R-Idaho) Oct. 19. The Dietary Supplement Fairness in Labeling and Advertising Act (S 1749) is similar to the bill Crapo introduced last session while a member of the House (1"The Tan Sheet" Oct. 5, 1998, p. 8). The new version, however, also would make FDA rescind its April 29 proposed rule on what constitutes an acceptable structure/function claim. In floor comments made when introducing the bill, Crapo stated that, with the proposal, FDA was "asserting responsibilities beyond congressional intent." The bill has been referred to the Senate Health, Education, Labor & Pensions Committee

Topics

UsernamePublicRestriction

Register

PS088935

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel